{"screen_name":{"0":"NEJM","1":"NEJM","2":"NEJM","3":"NEJM","4":"NEJM","5":"NEJM","6":"NEJM","7":"NEJM"},"tweet_id":{"0":1316853859646500865,"1":1316817855074258944,"2":1316816109279084545,"3":1316770810971877377,"4":1316755720088551425,"5":1316755712878362625,"6":1316740615485362176,"7":1316710412843245573},"is_retweet":{"0":false,"1":true,"2":false,"3":false,"4":false,"5":false,"6":false,"7":false},"text":{"0":"The NEJM Race and Medicine topic page features a selection of NEJM articles on race and medicine with implications for improving patient care, professional training, research, and public health. All articles assembled on the page are freely available.","1":"The International Antiviral Society\u2013USA Panel has updated its 2018 guidance on use of antiretroviral drugs to prevent and treat #HIV infection to include recommendations on long-acting injections.","2":"This long-term study compared mortality and life expectancy among patients who underwent bariatric surgery or received usual obesity care in the Swedish Obese Subjects study and in persons in the SOS reference study.","3":"In a 24-week trial involving patients with rheumatoid arthritis that was refractory to biologic agents, the JAK1 inhibitor upadacitinib was superior to abatacept in reducing disease activity as assessed by a composite measure of joint changes and CRP level.","4":"Visual Abstract: Upadacitinib or Abatacept for Rheumatoid Arthritis","5":"Free Access: NEJM Covid-19 Articles and Resources. #COVID19 #SARSCoV2","6":"\u201cHow are you holding up?\u201d This has become my pandemic refrain, the way I begin my virtual visits. These days, the world is especially heavy. As a primary care doctor seeing patients with a range of lived experiences, I cannot know, until I ask, the burdens they carry. #COVID19","7":"In this audio interview conducted on October 14, 2020, the editors discuss the fundamental concepts behind candidate vaccines against SARS-CoV-2 and the status of ongoing clinical trials."},"user_verified":{"0":true,"1":true,"2":true,"3":true,"4":true,"5":true,"6":true,"7":true},"created_at":{"0":"2020-10-15 21:30:00","1":"2020-10-15 19:06:56","2":"2020-10-15 19:00:00","3":"2020-10-15 16:00:00","4":"2020-10-15 15:00:02","5":"2020-10-15 15:00:00","6":"2020-10-15 14:00:01","7":"2020-10-15 12:00:00"},"retweet_count":{"0":82,"1":22,"2":50,"3":8,"4":12,"5":16,"6":38,"7":34},"favorite_count":{"0":395,"1":0,"2":101,"3":48,"4":41,"5":37,"6":132,"7":57},"user_location":{"0":"Boston, MA","1":"Boston, MA","2":"Boston, MA","3":"Boston, MA","4":"Boston, MA","5":"Boston, MA","6":"Boston, MA","7":"Boston, MA"},"user_url":{"0":"http:\/\/t.co\/MskhpINH4c","1":"http:\/\/t.co\/MskhpINH4c","2":"http:\/\/t.co\/MskhpINH4c","3":"http:\/\/t.co\/MskhpINH4c","4":"http:\/\/t.co\/MskhpINH4c","5":"http:\/\/t.co\/MskhpINH4c","6":"http:\/\/t.co\/MskhpINH4c","7":"http:\/\/t.co\/MskhpINH4c"},"entities":{"0":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"1":{"hashtags":[],"symbols":[],"user_mentions":[{"screen_name":"Physns1stWatch","name":"PhysiciansFirstWatch","id":130593087,"id_str":"130593087","indices":[3,18]}],"urls":[]},"2":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"3":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"4":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"5":{"hashtags":[{"text":"COVID19","indices":[51,59]},{"text":"SARSCoV2","indices":[60,69]}],"symbols":[],"user_mentions":[],"urls":[]},"6":{"hashtags":[{"text":"COVID19","indices":[269,277]}],"symbols":[],"user_mentions":[],"urls":[]},"7":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]}}}